Press Release: European scientists develop H7N1 avian flu vaccine

Supported by the EU Research Framework Programme, influenza experts from the UK, Italy and Norway, working with vaccine researchers from Sanofi Pasteur in France, developed the first human candidate vaccine for the H7N1 virus. Following this research breakthrough, it was planned that this new vaccine, called ‘RD-3’, would go into clinical trials in Spring 2006. Most vaccine development had centred on H5N1 thus far, the highly pathogenic form of the avian influenza ('bird flu').

• Primary Source

European Commission: DG Health and Consumer Protection: Animal Health & Welfare: Avian Influenza - introduction http://ec.europa.eu/comm/food/animal/diseases/controlmeasures/avian/index_en.htm

---